Central serous chorioretinopathy
Conditions
Interventions
We perform retinal laser photocoagulation in the peripheral area showing choroidal congestion in addition to the macular area for all the participants.
Sponsors
Gunma university hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Having been diagnosed with central serous chorioretinopathy 2) Having no other fundus diseases 3) Having not received any treatments for central serous chorioretinopathy 4) Being an outpatient 5) Having given written consent to participate the current study
Exclusion criteria
Exclusion criteria: 1) Showing dye leakage under the fovea or diffuse leakage in fluorescein angiography 2) Having received any steroid therapies 3) Having intraocular pressure of 21mmHg or more in the eye with central serous chorioretinopathy 4) Having been judged by doctors as inappropriate participants for the current study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The reduction of central choroidal thickness 12 weeks after retinal laser photocoagulation. | — |
Secondary
| Measure | Time frame |
|---|---|
| The reduction of diameters of choroidal veins and absorption of serous retinal detachment 12 weeks after retinal laser photocoagulation. | — |
Countries
Japan
Contacts
Public ContactHidetaka Matsumoto
Gunma University, School of Medicine Ophthalmology
Outcome results
None listed